tiprankstipranks
MannKind reports results from Phase 1 study of nintedanib DPI
PremiumThe FlyMannKind reports results from Phase 1 study of nintedanib DPI
22d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
26d ago
MannKind announces 30-week results from Phase 4 INHALE-3 study
Premium
The Fly
MannKind announces 30-week results from Phase 4 INHALE-3 study
2M ago
MannKind Announces Board of Directors Transition
PremiumCompany AnnouncementsMannKind Announces Board of Directors Transition
3M ago
MannKind director Kent Kresa to retire from board
Premium
The Fly
MannKind director Kent Kresa to retire from board
3M ago
MannKind reports Q2 adjusted EPS 5c, consensus 1c
Premium
The Fly
MannKind reports Q2 adjusted EPS 5c, consensus 1c
4M ago
MannKind to in-license iSPERSE technology from Pulmatrix
PremiumThe FlyMannKind to in-license iSPERSE technology from Pulmatrix
6M ago
Pulmatrix enters cross license agreement with MannKind
Premium
The Fly
Pulmatrix enters cross license agreement with MannKind
6M ago
MannKind reports Q1 EPS 5c, consensus 3c
Premium
The Fly
MannKind reports Q1 EPS 5c, consensus 3c
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100